Philip Wong

5.5k total citations · 1 hit paper
128 papers, 3.9k citations indexed

About

Philip Wong is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Philip Wong has authored 128 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 56 papers in Hepatology and 31 papers in Surgery. Recurrent topics in Philip Wong's work include Liver Disease Diagnosis and Treatment (46 papers), Liver Disease and Transplantation (30 papers) and Hepatitis C virus research (29 papers). Philip Wong is often cited by papers focused on Liver Disease Diagnosis and Treatment (46 papers), Liver Disease and Transplantation (30 papers) and Hepatitis C virus research (29 papers). Philip Wong collaborates with scholars based in Canada, United States and United Kingdom. Philip Wong's co-authors include Kevin D. Mullen, Piero Amodio, Hendrik Vilstrup, Karin Weißenborn, Jasmohan S. Bajaj, Juan Córdoba, Péter Ferenci, Marc Deschênes, Peter Ghali and K.S. Shah and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Philip Wong

118 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

2014 1.4k citations Hendrik Vilstrup, Piero Amodio et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Wong Canada	29	2.3k	2.2k	1.2k	471	309	128	3.9k
Beom Kyung Kim South Korea	43	5.1k 2.2×	4.7k 2.1×	919 0.8×	25 0.1×	329 1.1×	319	6.9k
L. Dalla Palma Italy	25	531 0.2×	954 0.4×	315 0.3×	337 0.7×	734 2.4×	80	2.5k
Charles M. Miller United States	53	5.8k 2.5×	2.8k 1.3×	5.7k 4.7×	41 0.1×	107 0.3×	330	9.6k
Roy Fox United Kingdom	29	780 0.3×	1.0k 0.5×	240 0.2×	88 0.2×	81 0.3×	103	3.5k
John J. Kim United States	22	1.2k 0.5×	463 0.2×	774 0.6×	782 1.7×	440 1.4×	55	2.5k
Christoph A. Binkert Switzerland	43	1.3k 0.5×	1.2k 0.5×	3.3k 2.7×	110 0.2×	1.3k 4.3×	164	9.1k
Luc Michel Belgium	24	1.2k 0.5×	493 0.2×	1.4k 1.2×	84 0.2×	361 1.2×	111	2.9k
Thomas Bardin France	54	305 0.1×	1.2k 0.5×	3.7k 3.0×	110 0.2×	410 1.3×	385	11.2k
Patricia McCormack United States	52	695 0.3×	949 0.4×	2.6k 2.1×	388 0.8×	844 2.7×	103	9.3k
Denis A. Cortese United States	37	1.3k 0.5×	679 0.3×	1.7k 1.4×	34 0.1×	283 0.9×	100	4.4k

Countries citing papers authored by Philip Wong

Since Specialization

Citations

This map shows the geographic impact of Philip Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Wong more than expected).

Fields of papers citing papers by Philip Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Wong. The network helps show where Philip Wong may publish in the future.

Co-authorship network of co-authors of Philip Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Wong. A scholar is included among the top collaborators of Philip Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Wong. Philip Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lafontaine, Julie, et al.. (2025). Iodine-125 plesiotherapy for murine tumor treatment. Radiation Oncology. 20(1). 78–78.

Dutra, Patrícia Maria Lourenço, et al.. (2025). Use of virtual reality as a radiology teaching tool for dental students. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 139(3). e68–e68.

Bienz, Marc, et al.. (2024). Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening?. Transfusion Medicine Reviews. 38(3). 150835–150835. 1 indexed citations

Chen, David, Ryan S. Huang, Jane Jomy, et al.. (2024). Performance of Multimodal Artificial Intelligence Chatbots Evaluated on Clinical Oncology Cases. JAMA Network Open. 7(10). e2437711–e2437711. 16 indexed citations

Sebastiani, Giada, Jovana Milić, Sahar Saeed, et al.. (2022). Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients. Journal of Personalized Medicine. 12(2). 282–282. 1 indexed citations

Osiowy, Carla, Sarah Haylock‐Jacobs, Scott Fung, et al.. (2022). Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada. JHEP Reports. 4(5). 100461–100461. 16 indexed citations

Farag, Mina, Scott Fung, Edward Tam, et al.. (2021). Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study. Journal of Viral Hepatitis. 28(6). 942–950. 18 indexed citations

Cooper, Curtis, David Wong, Sarah Haylock‐Jacobs, et al.. (2020). Distinct Hepatitis B and HIV co‐infected populations in Canada. Journal of Viral Hepatitis. 28(3). 517–527. 1 indexed citations

Lefebvre, Thierry, Claire Wartelle‐Bladou, Philip Wong, et al.. (2019). Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis. European Radiology. 29(12). 6477–6488. 77 indexed citations

10.

Wong, Philip, et al.. (2019). Transhepatic PEG Tube Placement. Clinical Gastroenterology and Hepatology. 18(9). e101–e101. 1 indexed citations

11.

Al‐Judaibi, Bandar, Benson Thomas, Philip Wong, et al.. (2018). Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience. Annals of Hepatology. 17(3). 437–443. 4 indexed citations

12.

Vilstrup, Hendrik, Piero Amodio, Jasmohan S. Bajaj, et al.. (2014). Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 60(2). 715–735. 1373 indexed citations breakdown →

13.

Wong, Philip, et al.. (2004). Randomized, controlled trial of the double setup tracheal tube during fibreoptic orotracheal intubation under general anaesthesia. British Journal of Anaesthesia. 92(4). 536–540. 3 indexed citations

14.

Rossol, S., Francisco Carmona-Torre, Philip Wong, et al.. (1995). Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology. 108(5). 1453–1463. 102 indexed citations

15.

Wong, Philip, George Marinos, Mark Peakman, et al.. (1995). FK506 in liver transplantation for chronic hepatitis B: In vitro studies on lymphocyte activation and virus replication. Liver Transplantation and Surgery. 1(6). 362–370. 15 indexed citations

16.

Shinn, Judy L., et al.. (1994). Preliminary estimates of nucleon fluxes in a water target exposed to solar-flare protons: BRYNTRN versus Monte Carlo code. STIN. 95. 10444. 6 indexed citations

17.

Devlin, J, Philip Wong, Roger Williams, et al.. (1994). FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. Transplant International. 7(s1). 64–69. 4 indexed citations

18.

Karani, John, N Heaton, Stephen H. Thomas, et al.. (1994). THE USE OF PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN HEPATIC ARTERY STENOSIS AFTER TRANSPLANTATION. Transplantation. 57(2). 228–230. 45 indexed citations

19.

Cross, W. G., et al.. (1992). BETA-RAY DOSE DISTRIBUTIONS FROM POINT SOURCES IN AN INFINITE WATER MEDIUM. Health Physics. 63(2). 160–171. 15 indexed citations

20.

Wong, Philip. (1967). A FORTRAN PROGRAM TO DETERMINE ABSORBED ORGAN DOSE DUE TO INHALATION OF RADIONUCLIDES,. Defense Technical Information Center (DTIC).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact